Lunding L, Webering S, Vock C, Behrends J, Wagner C, Holscher C, Fehrenbach H, Wegmann M. “Poly(inosinic-cytidylic) Acid–Triggered Exacerbation of Experimental Asthma Depends on IL-17A Produced by NK Cells.” Journal of Immunology. 2015;194.
Aparici M, Gavaldà A, Ramos I, Carcasona C, Otal R, Fernández-Blanco J, Montero J, García V, López R, De Alba J, Doe C, Puig C, Vilella D, Miralpeix M. “In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol.” Journal of Pharmacology. 2016; 770: 961-69.
Ezeamuzie C, El-Hashim A, Renno W, Edafiogho I. “Antiallergic and Antiasthmatic Effects of a Novel Enhydrazinone Ester (CEE-1): Inhibition of Activation of Both Mast Cells and Eosinophils.” Journal of Pharmacology and Experimental Therapeutics. 2014;350:444-454.
Poole J, Wyatt T, Kielian T, Oldenburg P, Gleason A, Bauer A, Golden G, West W, Sisson J, Romberger D. “Toll-like receptor 2 (TLR2) Regulates Organic Dust-Induced Airway Inflammation.” American Journal Respiratory Cellular and Molecular Biology. 2011;45:711-719.
Hatchwell L, Collison A, Girkin J, Parsons K, Li J, Zhang J, Phipps S, Knight D, Bartlett N, Johnston S, Foster P, Wark P, Mattes J. “Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia.” Thorax Online First. 2015.